Newsroom

Industry News

25 Nov

Calpian, Inc. CEO to Present at LD Micro Conference 2014 in Los Angeles

Calpian, Inc. (CLPI), a global mobile payments technology and processing company, announced that Harold Montgomery, chairman and chief executive officer, has been invited to present at the LD Micro conference at the Luxe Sunset Boulevard Hotel in Los Angeles on Thursday, Dec. 4 at 8 a.m. Pacific Time. Calpian...

Read more

21 Nov

Calpian’s Money-On-Mobile Extends Growth in India, Surpasses 112 Million Cumulative Unique Users, Grows Distribution Network to 225,000 Retailers

India’s leading mobile payments service provider continues growth trend, increases monthly processed volume 48 percent over past six months Calpian, Inc. (OTCQB: CLPI) announced that for the month ending October 31, 2014, its Mumbai-based subsidiary Money-On-Mobile has been accessed by more than 112 million cumulative unique users since its...

Read more

21 Nov

NephroGenex Announces Closing of $12 Million Term Loan Facility

NephroGenex, Inc. (Nasdaq:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, announced today that it has closed on a $12 million term loan facility with East West Bank. Funds from the term loan will be utilized for working capital purposes, including the advancement of...

Read more

20 Nov

Cesca Therapeutics Announces Filing of U.S. Pivotal IDE Application for No-Option Critical Limb Ischemia (“CLI”)

CLIRST III Study to Evaluate the SURGWERKS-CLI and VXP System in Patients With CLI Cesca Therapeutics Inc. (KOOL), an autologous cell-based regenerative medicine company developing proprietary devices and methods for cardiovascular, orthopedic and hematological/oncological procedures, today announced it has submitted an investigational device exemption (“IDE”) application to the U.S....

Read more

20 Nov

Intellipharmaceutics Notes Launch of 5mg Strength of Focalin XR(R) Generic by Teva

Intellipharmaceutics International Inc.(IPCI) (TSX:I) (“Intellipharmaceutics” or the “Company”), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that, based on information regarding recent generic introductions by Teva Pharmaceuticals (“Teva”) on its website (http://www.tevagenerics.com/products/new-teva-generics), it believes...

Read more

Page 1 of 3212345...102030...Last »

Latest Tweets